Thanks guys. Appreciate the feedback.
However it appears I have overlooked one of my favourites, so add this to the list.
POH is developing a revolutionary oxygel product.
It will not supersede or compete with a gel of it's like, as there is none.
Oxygel will have no competitors and aims to send oxycodone to peripheral opiod receptors to treat localized pain, whilst bypassing the systemic system.
Imagine the possibility of someone on long term systemic opiods, being able to treat their localized chronic pain with a non-systemic opiod gel.
And you sold at 16.5c.....
21 october 2011 - the arrival of phosphagenics, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(12.5%) |
Mkt cap ! $14.28M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $15.30K | 3.200M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 17347504 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 29054159 | 24 |
View Market Depth
| Last trade - 14.13pm 18/07/2025 (20 minute delay) ? |
| AVE (ASX) Chart |